When making important decisions about disease prevention, who do you listen to? Medical institutions? Or perhaps the people around you? Your answer might reveal more about your personal circumstances than you would expect.
FDA finalizes CAR-T and gene therapy guidance, offers support for accelerated approvals
The FDA on Monday finalized two guidance documents to help sponsors developing therapies in two crowded areas: gene therapies using genome editing and ex vivo-manufactured
January 30, 2024